101 related articles for article (PubMed ID: 21382861)
1. B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis.
Zhang H
Mult Scler; 2011 May; 17(5):639-40; author reply 641. PubMed ID: 21382861
[No Abstract] [Full Text] [Related]
2. B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
Okada K; Matsushita T; Kira J; Tsuji S
Neurology; 2010 Jan; 74(2):177-8. PubMed ID: 20065253
[No Abstract] [Full Text] [Related]
3. Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Kuwabara S
Arch Neurol; 2011 Jul; 68(7):913-7. PubMed ID: 21747031
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
Yang F; Huang D; Wu W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
[TBL] [Abstract][Full Text] [Related]
5. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.
Narikawa K; Misu T; Fujihara K; Nakashima I; Sato S; Itoyama Y
J Neuroimmunol; 2004 Apr; 149(1-2):182-6. PubMed ID: 15020078
[TBL] [Abstract][Full Text] [Related]
6. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
Vaknin-Dembinsky A; Brill L; Orpaz N; Abramsky O; Karussis D
Mult Scler; 2010 Dec; 16(12):1453-7. PubMed ID: 20935029
[TBL] [Abstract][Full Text] [Related]
7. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
Petereit HF; Rubbert-Roth A
Mult Scler; 2009 Feb; 15(2):189-92. PubMed ID: 18971221
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.
Uzawa A; Mori M; Arai K; Sato Y; Hayakawa S; Masuda S; Taniguchi J; Kuwabara S
Mult Scler; 2010 Dec; 16(12):1443-52. PubMed ID: 20739337
[TBL] [Abstract][Full Text] [Related]
10. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
Hosokawa T; Nakajima H; Doi Y; Sugino M; Kimura F; Hanafusa T; Takahashi T
J Neuroimmunol; 2011 Jul; 236(1-2):81-6. PubMed ID: 21621856
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder.
Masuda H; Mori M; Uchida T; Uzawa A; Ohtani R; Kuwabara S
J Neuroimmunol; 2017 Apr; 305():102-107. PubMed ID: 28284329
[TBL] [Abstract][Full Text] [Related]
12. NMO-IgG in the diagnosis of neuromyelitis optica.
Jarius S; Franciotta D; Bergamaschi R; Wright H; Littleton E; Palace J; Hohlfeld R; Vincent A
Neurology; 2007 Mar; 68(13):1076-7. PubMed ID: 17287449
[No Abstract] [Full Text] [Related]
13. [CSF-protein in neuromyelitis optica (author's transl)].
Krause KH; Berlit P; Schmitt HP; von Kummer R
Fortschr Neurol Psychiatr; 1982 Apr; 50(4):133-8. PubMed ID: 7095722
[No Abstract] [Full Text] [Related]
14. [Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica].
You XF; Ye J; Li CJ; Liao ZY; Sun H
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2477-80. PubMed ID: 21092475
[TBL] [Abstract][Full Text] [Related]
15. Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders.
Shu Y; Li H; Zhang L; Wang Y; Long Y; Li R; Qiu W; Lu Z; Hu X; Peng F
Brain Behav; 2017 Jan; 7(1):e00584. PubMed ID: 28127508
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic criteria in acute neuromyelitis].
Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
[TBL] [Abstract][Full Text] [Related]
17. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
[TBL] [Abstract][Full Text] [Related]
19. Importance of cerebrospinal fluid examination in differential diagnosis of Devic's neuromyelitis optica by multiple sclerosis.
Bergamaschi R
Neurol Sci; 2003 Oct; 24(3):95-6. PubMed ID: 14600818
[No Abstract] [Full Text] [Related]
20. High CSF neurofilament heavy chain levels in neuromyelitis optica.
Miyazawa I; Nakashima I; Petzold A; Fujihara K; Sato S; Itoyama Y
Neurology; 2007 Mar; 68(11):865-7. PubMed ID: 17353477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
